Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 283-585-7 | CAS number: 84682-23-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitization
In a Local Lymph Node Assay (LLNA) in mice (CBA/Ca strain), according to OECD Guideline 429 and SPL Standard Test method 595.12, T001159 did not elicit a SI>= 3 when tested up to 25% (Sanders, 2005). Therefore, the test item does not have to be classified as a skin sensitizer and has no obligatory labelling requirement for sensitization by skin contact according to the CLP Regulation (EC) No. 1272/2008.
Respiratory sensitization
No reliable respiratory sensitization study was available
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005-04-27 to 2005-05-12
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- 1) Insufficient information on the test substance, test animals and methodological details presented
- Qualifier:
- according to guideline
- Guideline:
- other: SPL Standard Test method 595.12
- Deviations:
- not specified
- GLP compliance:
- no
- Remarks:
- The study was conducted in a facility operating to Good Laboratory Practice within the UK national GLP monitoring programme, but no formal claim of GLP compliance is made for the study.
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- not specified
- Details on test animals and environmental conditions:
- TEST ANIMALS: no data
ENVIRONMENTAL CONDITIONS: no data
IN-LIFE DATES: no data - Vehicle:
- dimethylformamide
- Concentration:
- 5, 10 and 25% (w/w) in dimethylformamide
A further group of four animals was treated with dimethyl formamide alone. - No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS: no signs of systemic toxicity at a concentration of 25% w/w in a preliminary sighting test
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response: A stimulation index of 3.0 or greater indicates a positive result.
TREATMENT PREPARATION AND ADMINISTRATION:
- These groups were treated with 50 µL (25 µL per ear) of the test substance as a solution in dimethylformamide. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- other: 2,4 Dinitrobenzene sulphonic acid, sodium salt (DNBS), at 1%, 10%, 20% v/v in 1% pluronic L92 in distilled water.
- Statistics:
- no data
- Positive control results:
- see: any other information on results (here below)
- Parameter:
- SI
- Value:
- 1.86
- Test group / Remarks:
- 5% w/w in dimethyl formamide
- Parameter:
- SI
- Value:
- 1.65
- Test group / Remarks:
- 10% w/w in dimethyl formamide
- Parameter:
- SI
- Value:
- 1.86
- Test group / Remarks:
- 25% w/w in dimethyl formamide
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
Dpm/node obtained by dividing the Dpm valule by 8 (total number of lymph nodes)
vehicle control group, Dpm/node: 565.23
5% w/w group: Dpm/node: 1053.65
10% w/w group: Dpm/node: 933.70
25% w/w group: Dpm/node: 1049.38
DETAILS ON STIMULATION INDEX CALCULATION
The Stimulation Index (SI) was expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group
EC3 CALCULATION
no data
CLINICAL OBSERVATIONS:
No signs of systemic toxicity have been observed, no mortality observed
White residual test material on the ears observed in 10 and 25 %w/w groups 1 hour post dose on day 1 (only 25% w/w group) and days 2 and 3
BODY WEIGHTS
The mean body weight gain shown by the animals over the study period was considered to be normal. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was not considered a sensitiser under the conditions of the test as no SI value >= 3 has been observed when tested up to a concentration of 25% w/w.
Reference
Positive Control Local Lymph Node Assay in the Mouse (2005)
Start Date |
Finish Date |
Test Material |
Concentration |
Vehicle |
Stimulation Indexa |
Classificationb |
04/03/2005 |
10/03/2005 |
α‑Hexylcinnamaldehyde, tech., 85% |
5%, 10%, 25% v/v |
acetone/olive oil 4:1 |
2.76, 3.34, 8.91 |
Positive |
20/04/2005 |
26/04/2005 |
α‑Hexylcinnamaldehyde, tech., 85% |
5%, 10%, 25% v/v |
ethanol/distilled water |
2.64, 8.36, 12.94 |
Positive |
14/07/2005 |
20/07/2005 |
α‑Hexylcinnamaldehyde, tech., 85% |
5%, 10%, 25% v/v |
1% pluronic L92 in distilled water |
0.86, 1.50, 6.17 |
Positive |
14/07/2005 |
20/07/2005 |
2,4 Dinitrobenzene sulphonic acid, sodium salt (DNBS) |
1%, 10%, 20% v/v |
1% pluronic L92 in distilled water |
1.16, 9.59, 20.71 |
Positive |
a= Ratio of test to control lymphocyte proliferation
b= Stimulation index greater than 3.0 indicates a positive result
* = Standard Test Method 595 (Pooled nodes)
·= Standard Test Method 599 (Individual nodes)
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a Local Lymph Node Assay (LLNA) in mice (CBA/Ca strain), the skin sensitization potential of T001159 was investigated following topical application to the dorsal surface of the ear of mice (Sanders, 2005). Test item concentrations selected for the main study were based on the results of a preliminary sighting test. Three groups, each of four animals, were treated with 50 µL of the test material (25 µL per ear) as a solution in dimethyl formamide at concentrations of 5%, 10% and 25% w/w. A further group of four animals was treated with dimethyl formamide alone. Clinical observations and checks for mortality were recorded pre- and 1-hour post-dose on Days 1, 2, and 3 and on Days 4, 5, and 6. Body weights were recorded on Day 1 and 6. The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index).
Positive control tests using hexyl cinnamic aldehyde (CAS 101-86-0) at 5, 10 and 25% v/v in acetone/olive oil 4:1 and 2,4 Dinitrobenzene sulphonic acid, sodium salt (DNBS), at 1, 10, and 20% v/v in 1% pluronic L92 in distilled water elicited a positive classification.
No mortality or signs of systemic toxicity were observed. White residual test material on the ears observed in 10 and 25% w/w groups 1 hour post dose on day 1 (only 25% w/w group) and days 2 and 3. The mean body weight gain shown by the animals over the study period was considered to be normal. Mean DPM/node (DPM value/8 total lymph nodes) for the experimental groups treated with test item concentrations 5, 10 and 25% were 1053.65, 933.70 and 1049.38, respectively. The mean DPM/node value for the vehicle control group was 565.23. The SI values calculated for the substance concentrations 5, 10 and 25% were 1.86, 1.65 and 1.86, respectively. As T001159 did not elicit a stimulation index (SI) greater than or equal to 3 when tested up to 25%, it was considered to be a non-sensitiser under the conditions of the test.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Skin sensitisation:
As T001159 did not elicit a stimulation index (SI) greater than or equal to 3 when tested up to 25%, it is not considered to be a skin sensitizer under the conditions of the test.
Respiratory sensitisation:
No data were available to decide on the classification for respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.